- Home
- MTZ vs ICLR Comparison
MTZ vs ICLR Comparison
Compare MTZ & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTZ | ICLR |
|---|---|---|
| Founded | 1929 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 14.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | MTZ | ICLR |
|---|---|---|
| Price | $232.72 | $196.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 14 |
| Target Price | ★ $231.37 | $202.38 |
| AVG Volume (30 Days) | 733.5K | ★ 785.0K |
| Earning Date | 10-30-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.77 | N/A |
| EPS | 4.20 | ★ 7.47 |
| Revenue | ★ $13,762,473,000.00 | $8,102,602,000.00 |
| Revenue This Year | $15.48 | N/A |
| Revenue Next Year | $10.21 | $0.66 |
| P/E Ratio | $54.23 | ★ $25.24 |
| Revenue Growth | ★ 12.99 | N/A |
| 52 Week Low | $99.70 | $125.10 |
| 52 Week High | $233.14 | $228.29 |
Technical Indicators
Market Signals| Indicator | MTZ | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 67.99 |
| Support Level | $216.68 | $180.48 |
| Resistance Level | $225.50 | $184.93 |
| Average True Range (ATR) | 6.19 | 5.69 |
| MACD | 0.18 | 0.77 |
| Stochastic Oscillator | 82.96 | 97.30 |
Price Performance
Historical ComparisonAbout MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.